Get Our Popular Power Rankings for Stocks! Huge Short-Term Winners. HYRE +86% in 46 days.
Most Discussed Stocks through Posts and Reactions on SpeculatingStocks  NFLX  •  GRUB  •  DCAR  •  UVXY  •  FSM  •  BLDP  •  MXWL  •  DHR  •  TSLA  •  HIVE

Friday, October 12, 2018 Stock Pick

Stock Price: $5.14

T2 Biosystems, Inc. engages in the development of proprietary technology platform. It offers the T2 Magnetic Resonance technology which enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types.

TTOO's T2Direct Diagnostics identifies sepsis pathogens directly from whole blood in 3 to 5 hours. This is an improvement of waiting 1 to 5 days for blood culture results through the usual method. In terms of sepsis, this could be the difference between life and death as Sepsis affects over 200,000 US patients a year, and third leading cause of death. The company is also working on panels for bacteria and fungal pathogens and has had success in detecting early stage Lyme's disease.

Theranos wanted to disrupt the blood testing industry, but failed. The global blood testing industry is estimated to reach $62.9 billion by 2024. TTOO is taking a more calculated approach and finding success in niche areas such as sepsis and lyme's detection.

TTOO is trading at an RSI of 30.90 and nearly oversold at our stock pick price of $5.14. The stock corrected after climbing over $7.50 and lost even more territory than it should have with the overall market correction. TTOO is ready to start an uptrend from here.

Speculative Score: 3

1 Being the Least Speculative and Most Confident

10 Being the Most Speculative and Possibly the Most Risky

Untitled Document